Alkermes (ALKS) Equity Income (2011 - 2019)
Alkermes (ALKS) reported Equity Income of -$300000.0 for Q3 2019, down 400.0% year-over-year from $100000.0 in Q3 2018, and down 200.0% quarter-over-quarter from -$100000.0 in Q2 2019.
Alkermes (ALKS) Equity Income (2011 - 2019) Analysis & Trends
Alkermes (ALKS) has 9 years of Equity Income data on file, last reported at -$300000.0 in Q3 2019.
- Equity Income for Q3 2019 came in at -$300000.0, down 400.0% year-over-year; the trailing twelve-month figure through Dec 2019 was -$500000.0 (down 162.5% YoY), and the FY2020 annual result was $8.3 million, up 2175.0% from the prior year.
- Equity Income eased to -$300000.0 in Q3 2019 per ALKS's latest filing, from -$100000.0 in the prior quarter.
- Over five years, Equity Income peaked at $900000.0 in Q4 2018 and troughed at -$2.2 million in Q4 2017.
- A 5-year average of -$161111.1 and a median of -$100000.0 in 2015 frame the typical range for Equity Income.
- The sharpest annual moves came in 2016 and 2017: Equity Income soared 700.0% in 2016, then slumped 466.67% in 2017.
- A 5-year view of Equity Income shows it stood at -$100000.0 in 2015, then soared by 700.0% to $600000.0 in 2016, then tumbled by 466.67% to -$2.2 million in 2017, then soared by 140.91% to $900000.0 in 2018, then plunged by 133.33% to -$300000.0 in 2019.
- Business Quant data shows ALKS's Equity Income at -$300000.0 in Q3 2019, -$100000.0 in Q2 2019, and -$100000.0 in Q1 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Income (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 38.34 Bn | 34.60 Bn | 1.97 Bn | -1.00 Mn |
| 2 | Zoetis | 33.27 Bn | 31.33 Bn | 1.62 Bn | - |
| 3 | United Therapeutics | 23.75 Bn | 21.60 Bn | 648.10 Mn | - |
| 4 | Aurora Cannabis | 17.11 Bn | 17.03 Bn | 33.43 Mn | - |
| 5 | Neurocrine Biosciences | 16.37 Bn | 15.05 Bn | 800.70 Mn | 25.30 Mn |
| 6 | Elanco Animal Health | 11.78 Bn | 11.35 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.05 Bn | 6.54 Bn | -116.06 Mn | - |
| 8 | Lantheus Holdings | 6.49 Bn | 5.99 Bn | 230.92 Mn | 14.91 Mn |
| 9 | Hims & Hers Health | 6.19 Bn | 5.44 Bn | 396.79 Mn | -9.68 Mn |
| 10 | Liquidia | 5.63 Bn | 5.40 Bn | 121.79 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2019 | -300,000.00 |
| Jun 30, 2019 | -100,000.00 |
| Mar 31, 2019 | -100,000.00 |
| Dec 31, 2018 | 900,000.00 |
| Sep 30, 2018 | 100,000.00 |
| Jun 30, 2018 | -100,000.00 |
| Mar 31, 2018 | -100,000.00 |
| Dec 31, 2017 | -2.20 Mn |
| Sep 30, 2017 | 100,000.00 |
| Jun 30, 2017 | 100,000.00 |
| Mar 31, 2017 | -1.60 Mn |
| Dec 31, 2016 | 600,000.00 |
| Sep 30, 2016 | -300,000.00 |
| Jun 30, 2016 | -100,000.00 |
| Dec 31, 2015 | -100,000.00 |
| Sep 30, 2015 | 100,000.00 |
| Jun 30, 2015 | 100,000.00 |
| Mar 31, 2015 | 100,000.00 |
| Dec 31, 2014 | 4.80 Mn |
| Sep 30, 2014 | 4.00 Mn |